BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27291509)

  • 1. Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.
    Enriquez A; Antzelevitch C; Bismah V; Baranchuk A
    Heart Rhythm; 2016 Sep; 13(9):1878-84. PubMed ID: 27291509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
    Napolitano C; Bloise R; Monteforte N; Priori SG
    Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
    [No Abstract]   [Full Text] [Related]  

  • 3. The genetic and clinical features of cardiac channelopathies.
    Roberts JD; Gollob MH
    Future Cardiol; 2010 Jul; 6(4):491-506. PubMed ID: 20608822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sodium channelopathies.
    Amin AS; Asghari-Roodsari A; Tan HL
    Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden death and ion channel disease: pathophysiology and implications for management.
    Bastiaenen R; Behr ER
    Heart; 2011 Sep; 97(17):1365-72. PubMed ID: 21685181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion Channel Disorders and Sudden Cardiac Death.
    Garcia-Elias A; Benito B
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac ion channels in health and disease.
    Amin AS; Tan HL; Wilde AA
    Heart Rhythm; 2010 Jan; 7(1):117-26. PubMed ID: 19875343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postmortem genetic testing in sudden cardiac death due to ion channelopathies].
    Guan DW; Zhao R
    Fa Yi Xue Za Zhi; 2010 Apr; 26(2):120-7. PubMed ID: 20653139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes.
    Antzelevitch C
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2024-38. PubMed ID: 17586620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of atrial fibrillation: rotors, ionic determinants, and excitation frequency.
    Berenfeld O; Jalife J
    Cardiol Clin; 2014 Nov; 32(4):495-506. PubMed ID: 25443232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac ion channelopathies: A potential link between cardiomyopathies and cardiac arrhythmias].
    Schimpf R; Rudic B; Tülümen E; Papavassiliu T; Dösch C; Borggrefe M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):591-7. PubMed ID: 23483420
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal atrial repolarization and depolarization contribute to the inducibility of atrial fibrillation in Brugada syndrome.
    Kofune M; Watanabe I; Ohkubo K; Ashino S; Okumura Y; Nagashima K; Nakai T; Kasamaki Y; Hirayama A
    Int Heart J; 2010 May; 51(3):159-65. PubMed ID: 20558904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ventricular arrhythmias in suspected channelopathies.
    Obeyesekere MN; Antzelevitch C; Krahn AD
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):221-31. PubMed ID: 25691556
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
    Svendsen JH; Geelen P;
    Europace; 2010 May; 12(5):741-2. PubMed ID: 20421225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N; Pedalino R; Himel H
    Curr Vasc Pharmacol; 2009 Jul; 7(3):358-66. PubMed ID: 19601860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies.
    Amarouch MY; El Hilaly J
    Cardiovasc Ther; 2020; 2020():6615038. PubMed ID: 33381229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial arrhythmias in the inherited long QT syndrome: laboratory quirk or clinical arrhythmia?
    Vincent GM
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10):1034-5. PubMed ID: 14521654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.